Cart
sales@molnova.com
Methyl 4-bromopyrrole-2-carboxylate
CAS No. 934-05-4
Methyl 4-bromopyrrole-2-carboxylate( methyl 4-bromo-1H-pyrrole-2-carboxylate | 4-Bromo-2-(methoxycarbonyl)-1H-pyrrole )
Catalog No. M29527 CAS No. 934-05-4
Methyl 4-bromopyrrole-2-carboxylate is a marine derived natural products found in Lissodendoryx sp.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 200MG | 45 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameMethyl 4-bromopyrrole-2-carboxylate
-
NoteResearch use only, not for human use.
-
Brief DescriptionMethyl 4-bromopyrrole-2-carboxylate is a marine derived natural products found in Lissodendoryx sp.
-
DescriptionMethyl 4-bromopyrrole-2-carboxylate is a marine derived natural products found in Lissodendoryx sp.
-
In Vitro——
-
In Vivo——
-
Synonymsmethyl 4-bromo-1H-pyrrole-2-carboxylate | 4-Bromo-2-(methoxycarbonyl)-1H-pyrrole
-
PathwayOthers
-
TargetOther Targets
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number934-05-4
-
Formula Weight204.02
-
Molecular FormulaC6H6BrNO2
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : ≥ 100 mg/mL (490.15 mM)
-
SMILESO=C(OC)C1=CC(Br)=CN1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
-
Glimepiride sulfonam...
Glimepiride sulfonamide is an antiinflammatory agent.
-
Letaplimab
Letaplimab (IBI-188) is a humanized IgG4 class antibody targeting CD47 and is often used in combination with azacitidine for the treatment of primary diagnosis of intermediate- to high-risk myelodysplastic syndromes.
-
26Rfa, Hypothalamic ...
This human neuropeptide of the RFamide peptide family with orexigenic activity may be also involved in the control of feeding behavior. The 26RFa gene is exclusively expressed in the ventromedial hypothalamic nucleus and in the lateral hypothalamic area. The primary structures of human, rat, and frog 26RFa exhibit ≈80% identity. Other data suggest also the potential role of the 26RFa peptide in the control of the gonadotropic axis.
